// App-Quantinova.ai

POS0734 (2021) : EXTRAPOLATION OF LONG-TERM OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS: REPLICATING A HOPKINS LUPUS COHORT ANALYSIS WITH THE SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS (SLICC) INCEPTION COHORT

Researchers

Presenter

  • A. E. Clarke

Principal Investigators

  • V. Paly

  • I. N. Bruce

  • A. Briggs

  • Y. Zhang

  • J. Choi

  • A. Brennan

Medical Centers

  • University of Calgary, Division of Hematology, Calgary, AB, Canada

  • McGill University Health Centre - Research Institute, Montreal, Quebec, Canada

  • ICON plc, Global Health Economics and Outcomes Research (GHEOR), New York, United States of America

  • University of Manchester, The Kellgren Centre for Rheumatology, Manchester, United Kingdom

  • ICON plc, Global Health Economics and Outcomes Research (GHEOR), Stockholm, Sweden

  • London School of Hygiene & Tropical Medicine, Department of Health Services Research and Policy, London, United Kingdom

  • Bristol Myers Squibb, Worldwide HEOR, Lawrenceville, United States of America

  • The University of Sheffield, Health Economics and Decision Science, School of Health and Related Research, Sheffield, United Kingdom

Locations

  • Canada

  • United States

  • United Kingdom

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Prednisone

Outcome

  • N/A


Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Genzyme and Sanofi

Result

  • N/A